Last 356.50 GBp
Change Today +13.50 / 3.94%
Volume 68.3K
SKP On Other Exchanges
Symbol
Exchange
London
OTC US
Frankfurt
OTC US
As of 11:35 AM 11/28/14 All times are local (Market data is delayed by at least 15 minutes).

skyepharma plc (SKP) Snapshot

Open
337.00 GBp
Previous Close
343.00 GBp
Day High
357.75 GBp
Day Low
337.00 GBp
52 Week High
10/27/14 - 374.00 GBp
52 Week Low
12/2/13 - 97.65 GBp
Market Cap
373.7M
Average Volume 10 Days
113.7K
EPS TTM
-0.22 GBp
Shares Outstanding
104.8M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for SKYEPHARMA PLC (SKP)

Related News

No related news articles were found.

skyepharma plc (SKP) Related Businessweek News

No Related Businessweek News Found

skyepharma plc (SKP) Details

Skyepharma PLC develops oral and inhalation pharmaceutical products. The company’s products include flutiform, a unique inhaled combination product which has been approved in 31 countries; and Pacira’s Exparel, an amide local anesthetic indicated for single-dose infiltration into the surgical site to produce extended postsurgical analgesia. Skyepharma’s inhalation technology has been licensed to GlaxoSmithKline for use in Breo/Relvar, Anoro, and Incruse. Skyepharma is also developing a novel inhaled therapy, SKP-2075, as a potential anti-inflammatory treatment for COPD. Skyepharma’s oral technologies are used in 10 products marketed by various companies in approximately 80 countries. The company has partnerships with various companies, including GlaxoSmithKline, Sanofi, Mundipharma, and Kyorin worldwide. Skyepharma PLC was founded in 1910 and is headquartered in London, the United Kingdom.

79 Employees
Last Reported Date: 03/28/14
Founded in 1910

skyepharma plc (SKP) Top Compensated Officers

Chief Executive Officer and Executive Directo...
Total Annual Compensation: 567.0K GBP
Chief Financial Officer and Executive Directo...
Total Annual Compensation: 74.0K GBP
Compensation as of Fiscal Year 2013.

skyepharma plc (SKP) Key Developments

SkyePharma plc Presents at Jefferies 2014 Global Healthcare Conference: London, Nov-20-2014 12:20 PM

SkyePharma plc Presents at Jefferies 2014 Global Healthcare Conference: London, Nov-20-2014 12:20 PM. Venue: The Waldorf Hilton, Aldwych, London, United Kingdom. Speakers: Peter William Grant, Chief Executive Officer and Executive Director.

SkyePharma plc Presents at Stifel Healthcare Conference 2014, Nov-19-2014 04:10 PM

SkyePharma plc Presents at Stifel Healthcare Conference 2014, Nov-19-2014 04:10 PM. Venue: The Palace Hotel, 455 Madison Ave, New York, NY 10022, United States. Speakers: Andrew Derodra, Chief Financial Officer and Executive Director.

SkyePharma plc - Analyst/Investor Day

SkyePharma plc - Analyst/Investor Day

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SKP:LN 356.50 GBp +13.50

SKP Competitors

Market data is delayed at least 15 minutes.

Company Last Change
BioDelivery Sciences International Inc $15.35 USD -0.45
Flamel Technologies SA $14.29 USD -0.04
Onxeo €5.59 EUR -0.19
Vectura Group PLC 127.00 GBp -3.25
Veloxis Pharmaceuticals A/S kr1.08 DKK 0.00
View Industry Companies
 

Industry Analysis

SKP

Industry Average

Valuation SKP Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 3.2x
Price/Book 9.2x
Price/Cash Flow NM Not Meaningful
TEV/Sales 5.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SKYEPHARMA PLC, please visit www.skyepharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.